Long non-coding RNA profile study identifies an immune-related lncRNA prognostic signature for prostate adenocarcinoma.
Sign Up to like & getrecommendations! Published in 2021 at "International immunopharmacology"
DOI: 10.1016/j.intimp.2021.108267
Abstract: Prostate adenocarcinoma (PRAD) is the highest incidence rate of male urogenital morbidity worldwide. Long non-coding RNAs (lncRNAs), as a significant class of gene expression regulators, play a critical role in immune regulation. The purpose of… read more here.
Keywords: prostate adenocarcinoma; immune related; related lncrna; study ... See more keywords
The 99mTc-MIP-1404 PSMA Uptake in the Isolated Paratracheal Lymph Node From the Prostate Adenocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000004384
Abstract: Abstract The oncologist consulted a 56-year-old man after receiving prostate-specific antigen screening results. Prostate-specific antigen level during the screen time was 33 ng/mL. As a result, poorly differentiated prostate adenocarcinoma with a Gleason score of… read more here.
Keywords: 99mtc mip; prostate; mip 1404; 1404 psma ... See more keywords
Metastasis of Prostate Adenocarcinoma in the Mandible: Rare Occurrence in Maxillary Bones.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Craniofacial Surgery"
DOI: 10.1097/scs.0000000000005935
Abstract: OBJECTIVE This article describes the case report of a prostate adenocarcinoma in the mandible. BACKGROUND Prostate adenocarcinoma is a malignant tumor common in men from the fourth decade of life. The occurrence of oral metastatic… read more here.
Keywords: adenocarcinoma; rare occurrence; metastasis; prostate adenocarcinoma ... See more keywords
Dishevelled segment polarity protein 3 (DVL3): a novel and easily applicable recurrence predictor in localised prostate adenocarcinoma
Sign Up to like & getrecommendations! Published in 2017 at "BJU International"
DOI: 10.1111/bju.13783
Abstract: To identify new biomarkers for biochemical recurrence (BCR) of prostate adenocarcinoma. read more here.
Keywords: prostate adenocarcinoma; recurrence; dishevelled segment; segment polarity ... See more keywords
Painful testicular metastasis from prostate adenocarcinoma
Sign Up to like & getrecommendations! Published in 2017 at "BMJ Case Reports"
DOI: 10.1136/bcr-2017-219963
Abstract: A 60-year-old man presented with unilateral testicular pain and urinary frequency. His presenting prostate-specific antigen (PSA) was 100 ng/mL, and a biopsy revealed Gleason 4+4 prostate adenocarcinoma. The significance of his initial PSA was somewhat complicated by… read more here.
Keywords: prostate; prostate adenocarcinoma; psa; painful testicular ... See more keywords
Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccine
Sign Up to like & getrecommendations! Published in 2021 at "Molecular Cancer"
DOI: 10.1186/s12943-021-01452-1
Abstract: Prostate adenocarcinoma (PRAD) is a leading cause of death among men. Messenger ribonucleic acid (mRNA) vaccine presents an attractive approach to achieve satisfactory outcomes; however, tumor antigen screening and vaccination candidates show a bottleneck in… read more here.
Keywords: tumor; prostate adenocarcinoma; mrna vaccine; tumor antigens ... See more keywords
Dural metastasis of prostate adenocarcinoma with spontaneous subdural hematoma: an unusual mimicker of meningioma.
Sign Up to like & getrecommendations! Published in 2019 at "Arquivos de neuro-psiquiatria"
DOI: 10.1590/0004-282x20190086
Abstract: A 65-year-old male presented with abrupt onset of right hemiparesis. He was previously diagnosed with advanced adenocarcinoma of the prostate. Magnetic resonance imaging showed an extra-axial expansile lesion, located in the left perirolandic region associated… read more here.
Keywords: dural metastasis; adenocarcinoma; prostate; subdural hematoma ... See more keywords
18F-Prostate-Specific Membrane Antigen and 18F-Fluorodeoxyglucose PET/CT Unmasked the Characteristics of Prostate Lymphoma: A Case Report and Literature Review
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.842093
Abstract: Prostate lymphoma (PL) is rarely observed and may be concurrently presented with prostate adenocarcinoma. Moreover, the appearance of PL on conventional imaging is similar with prostate adenocarcinoma. Thus, most of PL is diagnosed through prostate… read more here.
Keywords: prostate specific; prostate; antigen; prostate adenocarcinoma ... See more keywords
Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.1037535
Abstract: Introduction Prostate adenocarcinoma (PRAD) is a highly aggressive malignancy with high mortality and poor prognosis, and its potential mechanism remains unclear. Our study aimed to identify novel markers for the prognosis of PRAD using bioinformatics… read more here.
Keywords: prognostic biomarker; ifitm1 prognostic; prad; prostate adenocarcinoma ... See more keywords
A Deep Learning Model for Prostate Adenocarcinoma Classification in Needle Biopsy Whole-Slide Images Using Transfer Learning
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostics"
DOI: 10.3390/diagnostics12030768
Abstract: The histopathological diagnosis of prostate adenocarcinoma in needle biopsy specimens is of pivotal importance for determining optimum prostate cancer treatment. Since diagnosing a large number of cases containing 12 core biopsy specimens by pathologists using… read more here.
Keywords: prostate; whole slide; prostate adenocarcinoma; slide images ... See more keywords
Nur77 Serves as a Potential Prognostic Biomarker That Correlates with Immune Infiltration and May Act as a Good Target for Prostate adenocarcinoma
Sign Up to like & getrecommendations! Published in 2023 at "Molecules"
DOI: 10.3390/molecules28031238
Abstract: Prostate adenocarcinoma (PRAD) is the most frequent malignancy, and is the second leading cause of death due to cancer in men. Thus, new prognostic biomarkers and drug targets for PRAD are urgently needed. As we… read more here.
Keywords: prognostic biomarker; immune infiltration; prad; prostate adenocarcinoma ... See more keywords